Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Novo Nordisk Product Formulary Information | NNI Decision |
Description | Formulary information for insurance and medical billing Find formulary information for insurance and medical billing professionals to Novo Nordisk products for rare bleeding |
Keywords | N/A |
WebSite | nnidecisionmaker.com |
Host IP | 72.3.137.119 |
Location | United States |
Site | Rank |
US$1,515,650
Last updated: 2023-05-19 04:55:19
nnidecisionmaker.com has Semrush global rank of 6,983,345. nnidecisionmaker.com has an estimated worth of US$ 1,515,650, based on its estimated Ads revenue. nnidecisionmaker.com receives approximately 174,883 unique visitors each day. Its web server is located in United States, with IP address 72.3.137.119. According to SiteAdvisor, nnidecisionmaker.com is safe to visit. |
Purchase/Sale Value | US$1,515,650 |
Daily Ads Revenue | US$1,400 |
Monthly Ads Revenue | US$41,972 |
Yearly Ads Revenue | US$503,662 |
Daily Unique Visitors | 11,659 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
nnidecisionmaker.com. | A | 300 | IP: 72.3.137.119 |
nnidecisionmaker.com. | NS | 86400 | NS Record: ns.rackspace.com. |
nnidecisionmaker.com. | NS | 86400 | NS Record: ns2.rackspace.com. |
nnidecisionmaker.com. | TXT | 300 | TXT Record: 4jw14jmckztrsxfglvw718cvdd6gk9b3 |
nnidecisionmaker.com. | TXT | 300 | TXT Record: google-site-verification=JCetPYTL1OaFRitMLsU98x6Qk1050Ec7vpeT8hvYZhw |
nnidecisionmaker.com. | TXT | 300 | TXT Record: 3n9zv3kyb3x017q690wctvxwnk6bfh3j |
NNI Decision Maker Home Esperoct ® NovoSeven ® RT Rebinyn ® Novoeight ® Formulary information for insurance and medical billing professionals. Novo Nordisk has a long history of helping people who live with chronic diseases. Here you’ll have quick access to the formulary information you need for each of the products listed below. View formulary information Prescribing Information View formulary information Prescribing Information View formulary information Prescribing Information View formulary information Prescribing Information You are about to leave nnidecisionmaker.com. Click "Continue" to leave this site and come back to visit us another time. Click "Cancel" to stay on nnidecisionmaker.com. Cancel Continue Selected Important Safety Information for NovoSeven ® RT WARNING: THROMBOSIS Serious arterial and venous thrombotic events following administration of NovoSeven ® RT have been reported Discuss the risks and explain the signs and symptoms of thrombotic and thromboembolic events |
HTTP/1.1 301 Moved Permanently Date: Tue, 30 Aug 2022 08:41:27 GMT Server: Apache/2.4.43 (IUS) OpenSSL/1.0.2k-fips Communique/4.3.2 Location: https://www.nnidecisionmaker.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 date: Tue, 30 Aug 2022 08:41:27 GMT server: Apache/2.4.43 (IUS) OpenSSL/1.0.2k-fips Communique/4.3.2 last-modified: Fri, 26 Aug 2022 18:37:22 GMT etag: "7d73-5e729346dd9eb" accept-ranges: bytes content-length: 32115 vary: Accept-Encoding content-disposition: inline content-type: text/html; charset=UTF-8 |
Domain Name: NNIDECISIONMAKER.COM Registry Domain ID: 2398128107_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.dynadot.com Registrar URL: http://www.dynadot.com Updated Date: 2021-06-04T14:47:21Z Creation Date: 2019-06-03T17:06:19Z Registry Expiry Date: 2023-06-03T17:06:19Z Registrar: DYNADOT, LLC Registrar IANA ID: 472 Registrar Abuse Contact Email: abuse@dynadot.com Registrar Abuse Contact Phone: +16502620100 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS.RACKSPACE.COM Name Server: NS2.RACKSPACE.COM DNSSEC: unsigned >>> Last update of whois database: 2022-08-30T08:43:33Z <<< |